Found: 7
Select item for more details and to access through your institution.
Surrogate marker analysis in cancer clinical trials through time-to-event mediation techniques.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A multiresolution approach to time warping achieved by a Bayesian prior-posterior transfer fitting strategy.
- Published in:
- Journal of the Royal Statistical Society: Series B (Statistical Methodology), 2010, v. 72, n. 5, p. 673, doi. 10.1111/j.1467-9868.2010.00752.x
- By:
- Publication type:
- Article
Discordant assessment of tumor biomarkers by histopathological and molecular assays in the EORTC randomized controlled 10041/BIG 03-04 MINDACT trial breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 155, n. 3, p. 463, doi. 10.1007/s10549-016-3690-6
- By:
- Publication type:
- Article
A single, oral dose of the TLR7 agonist JNJ-64794964 induces transcriptomic and phenotypic changes in peripheral immune cells in healthy adults.
- Published in:
- Antiviral Therapy, 2023, v. 28, n. 3, p. 1, doi. 10.1177/13596535231172878
- By:
- Publication type:
- Article
Population pharmacokinetic/pharmacodynamic models of JNJ-64794964, a toll-like receptor 7 agonist, in healthy adult participants.
- Published in:
- Antiviral Therapy, 2023, v. 28, n. 1, p. 1, doi. 10.1177/13596535231151626
- By:
- Publication type:
- Article
Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes.
- Published in:
- British Journal of Cancer, 2019, v. 120, n. 9, p. 913, doi. 10.1038/s41416-019-0420-y
- By:
- Publication type:
- Article
Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes.
- Published in:
- 2019
- By:
- Publication type:
- journal article